Ap pharma also received a CRL with no additional clinical trials in 2010, even to this day they havn't resubmitted NDA. Also Navb can only tap $15,mill loan, they must raise cash before they resubmit NDA. CEO hasn't give any details on timelines. Biotech CEO's always mislead. Holding 388 $3 put contracts AVG price $0.25 Will see......